Jiayin Yao

639 total citations
32 papers, 466 citations indexed

About

Jiayin Yao is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Jiayin Yao has authored 32 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Jiayin Yao's work include Inflammatory Bowel Disease (14 papers), Autoimmune and Inflammatory Disorders (7 papers) and Microscopic Colitis (7 papers). Jiayin Yao is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Autoimmune and Inflammatory Disorders (7 papers) and Microscopic Colitis (7 papers). Jiayin Yao collaborates with scholars based in China and United Kingdom. Jiayin Yao's co-authors include Min Zhi, Minhu Chen, Chujun Li, Pinjin Hu, Xiang Gao, Xiaobo Yang, Xinhua Yao, Jun Hu, Min Zhang and Huanliang Liu and has published in prestigious journals such as Gastroenterology, IEEE Access and Frontiers in Immunology.

In The Last Decade

Jiayin Yao

28 papers receiving 461 citations

Peers

Jiayin Yao

EPIDE

SURGE

GENET

PRM

Junxiang Li China

Juliette Joubert‐Zakeyh France

Kazunari Kanke Japan

Mosang Yu China

Jian Long China

Kazuki Kakimoto Japan

Khaly Mbodji Canada

Pierre Rousselot France

Junbin Yan China

Junxiang Li China

Jiayin Yao

132 ×1.0

EPIDE

198 ×1.6

166 ×1.6

SURGE

70 ×0.7

GENET

36 ×0.4

PRM

Citations per year, relative to Jiayin Yao Jiayin Yao (= 1×) peers Junxiang Li

Countries citing papers authored by Jiayin Yao

Since Specialization

Citations

This map shows the geographic impact of Jiayin Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayin Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayin Yao more than expected).

Fields of papers citing papers by Jiayin Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayin Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayin Yao. The network helps show where Jiayin Yao may publish in the future.

Co-authorship network of co-authors of Jiayin Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayin Yao. A scholar is included among the top collaborators of Jiayin Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayin Yao. Jiayin Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Hao, et al.. (2025). DOP058 Efficacy and Safety of Vedolizumab Combined with Upadacitinib in Moderate-to-Severe Ulcerative Colitis: A Multicenter, Prospective, Randomized Controlled Trial. Journal of Crohn s and Colitis. 19(Supplement_1). i197–i199.

Gan, Ying, et al.. (2024). Graves’ disease and the risk of five autoimmune diseases: A Mendelian randomization and colocalization study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(5). 103023–103023. 3 indexed citations

Liu, Ling, Meng Fan, Tao Liu, et al.. (2024). Prediction of the Short-Term Effectiveness of Ustekinumab in Patients with Moderate to Severe Crohn’s Disease. Journal of Inflammation Research. Volume 17. 9181–9191.

Yao, Xiaotong, et al.. (2024). YOLO-Wheat: A Wheat Disease Detection Algorithm Improved by YOLOv8s. IEEE Access. 12. 133877–133888. 2 indexed citations

Deng, Jun, Yi Lü, Tao Liu, et al.. (2024). Changes in clinical features and seasonal variations of Crohn’s disease at diagnosis: a 10-year observational study in China. Frontiers in Medicine. 11. 1489699–1489699. 1 indexed citations

Gan, Ying, et al.. (2024). Associations of genetically predicted iron status with 24 gastrointestinal diseases and gut microbiota: a Mendelian randomization study. Frontiers in Genetics. 15. 1406230–1406230.

Peng, Xiang, Jiayin Yao, Xiaolan Li, et al.. (2023). Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study. Journal of Ovarian Research. 16(1). 34–34. 6 indexed citations

Yao, Jiayin, Jie Zhou, Min Zhang, et al.. (2023). Computed tomography‐based radiomics nomogram using machine learning for predicting 1‐year surgical risk after diagnosis of Crohn's disease. Medical Physics. 50(6). 3862–3872. 10 indexed citations

Yao, Jiayin, Xiang Peng, Tao Su, et al.. (2023). Extra intravenous Ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn’s disease. Frontiers in Medicine. 10. 1105981–1105981. 5 indexed citations

10.

Yao, Jiayin, et al.. (2023). Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease. Expert Review of Gastroenterology & Hepatology. 17(4). 379–384. 2 indexed citations

11.

Yao, Jiayin, Heng Zhang, Tao Su, et al.. (2023). Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis. Journal of Clinical Medicine. 12(3). 939–939. 11 indexed citations

12.

Su, Peizhu, Jing Yu, Junjun Liu, et al.. (2023). Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study. Clinical and Experimental Medicine. 23(7). 4011–4019. 31 indexed citations

13.

Zhao, Junzhang, Wei Wang, Tao Liu, et al.. (2022). MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells. BMC Cancer. 22(1). 1290–1290. 4 indexed citations

14.

Hu, Jun, Sijing Cheng, Jiayin Yao, et al.. (2022). Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease. Frontiers in Immunology. 13. 947313–947313. 33 indexed citations

15.

Hu, Bang, et al.. (2021). Predictors of Chronic Postsurgical Pain in Elderly Patients Undergoing Hip Arthroplasty: A Multi-Center Retrospective Cohort Study. International Journal of General Medicine. Volume 14. 7885–7894. 12 indexed citations

16.

Hu, Bang, et al.. (2020). CircFAT1 Suppresses Colorectal Cancer Development Through Regulating miR-520b / UHRF1 Axis or miR-302c-3p / UHRF1 Axis. Cancer Biotherapy and Radiopharmaceuticals. 36(1). 45–57. 16 indexed citations

17.

Yao, Jiayin, Yi Jiang, Jia Ke, et al.. (2020). Development of a prognostic model for one-year surgery risk in Crohn’s disease patients: A retrospective study. World Journal of Gastroenterology. 26(5). 524–534. 13 indexed citations

18.

Lu, Yi, et al.. (2018). Gentiopicroside Ameliorates Diabetic Peripheral Neuropathy by Modulating PPAR- Γ/AMPK/ACC Signaling Pathway. Cellular Physiology and Biochemistry. 50(2). 585–596. 33 indexed citations

19.

Rao, Benqiang, Yuanhong Gao, Jun Huang, et al.. (2011). Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis. International Journal of Colorectal Disease. 26(5). 593–601. 46 indexed citations

20.

Yao, Jiayin, Min Zhi, & Minhu Chen. (2011). Effect of silybin on high-fat-induced fatty liver in rats. Brazilian Journal of Medical and Biological Research. 44(7). 652–659. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact